Hua Medicine Ltd. 2552

HKEX · Hong Kong SAR China · Health Technology

HKD 2.35+0.02 (+0.64%)

Market closed· Oct 2, 2026, 7:58 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Hua Medicine Ltd. 2552

HKEX · Hong Kong SAR China · Health Technology

HKD 2.35+0.02 (+0.64%)

Market closed· Oct 2, 2026, 7:58 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-35.75% · 6MFull-screen chart

Open HKD 2.34High HKD 2.37Low HKD 2.23Close HKD 2.35Volume 642.50K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: HKD 2.33
Day range: HKD 2.23 – HKD 2.37
52-week range: HKD 1.97 – HKD 4.95
Volume: 642.50K
Market cap: HKD 2.26B
P/E (last fiscal year): 1.9
Next earnings date: 2027-04-01
Avg. volume (1Y): 3.14M

Performance

1 week

-1.47%

1 month

-1.26%

3 months

-10.15%

6 months

-35.75%

Year to date

-23.11%

1 year

-51.04%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Hong Kong SAR China
Exchange: HKEX
Shares outstanding: 998.64M
Employees: 328
ISIN: KYG4644K1022
Beta: 1.62

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceMar 03, 2026

Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China

Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552.HK) announced today that its global first-in-class glucokinase activator (GKA) dorzagliatin (Trade name: MYHOMSIS®, 華領片®) has been approved for marketing by the Pharmaceutical Service of the Department of Health of the Hong Kong Special Administrative Region of China for the treatment of Type 2 diabetes in adults.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.